Mangoceuticals, Price To Book Ratio from 2010 to 2025

MGRX Stock   2.47  0.34  12.10%   
Mangoceuticals, Common Price To Book Ratio yearly trend continues to be fairly stable with very little volatility. Price To Book Ratio is likely to outpace its year average in 2025. Price To Book Ratio is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter's book value per share. View All Fundamentals
 
Price To Book Ratio  
First Reported
2010-12-31
Previous Quarter
0.34339979
Current Value
0.36
Quarterly Volatility
28 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mangoceuticals, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals, Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 768 K, Interest Expense of 14.4 K or Selling General Administrative of 3.2 M, as well as many indicators such as Price To Sales Ratio of 9.61, Dividend Yield of 0.14 or PTB Ratio of 0.36. Mangoceuticals, financial statements analysis is a perfect complement when working with Mangoceuticals, Common Valuation or Volatility modules.
  
Check out the analysis of Mangoceuticals, Common Correlation against competitors.

Latest Mangoceuticals, Common's Price To Book Ratio Growth Pattern

Below is the plot of the Price To Book Ratio of Mangoceuticals, Common Stock over the last few years. It is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter's book value per share. Mangoceuticals, Common's Price To Book Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mangoceuticals, Common's overall financial position and show how it may be relating to other accounts over time.
Price To Book Ratio10 Years Trend
Slightly volatile
   Price To Book Ratio   
       Timeline  

Mangoceuticals, Price To Book Ratio Regression Statistics

Arithmetic Mean(46,495)
Geometric Mean6,241
Coefficient Of Variation(60.18)
Mean Deviation23,460
Median(62,135)
Standard Deviation27,980
Sample Variance782.9M
Range63.8K
R-Value0.75
Mean Square Error366.8M
R-Squared0.56
Significance0.0008
Slope4,409
Total Sum of Squares11.7B

Mangoceuticals, Price To Book Ratio History

2025 0.36
2024 0.34
2023 7.65
2022 1691.94

About Mangoceuticals, Common Financial Statements

Mangoceuticals, Common investors use historical fundamental indicators, such as Mangoceuticals, Common's Price To Book Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mangoceuticals, Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Book Ratio 0.34  0.36 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mangoceuticals, Stock Analysis

When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.